TD Asset Management »

Biomarin Pharmaceutical shares owned by TD Asset Management

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by TD Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $390k 400k 0.97

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Cibc Cad (CM)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Enbridge (ENB)
Amazon (AMZN)
Manulife Finl Corp (MFC)
Canadian Pacific Kansas City (CP)
Johnson & Johnson (JNJ)

View all positions for TD Asset Management

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Oaktree Capital Management
Capstone Investment Advisors
Man Group
Camden Asset Management
Opti Capital Management
MacKay Shields
Jpmorgan Chase & Co
Verition Fund Management
Victory Capital Management
Thrivent Financial for Lutherans
Toronto-Dominion Bank
BlackRock
State Street Corporation
DeepCurrents Investment Group

View all funds holding Biomarin Pharmaceutical